Greece Approves Breakthrough Pancreatic Cancer Treatment
A new drug that doubled survival among patients with advanced pancreatic cancer in a clinical trial offers fresh hope for a disease that remains one of the most difficult cancers to treat, according to Professor Grigoris Tsiotos of the Mayo Clinic and president of the Hellenic Pancreas Institute. The drug, daraxonrasib, helped patients with metastatic …